For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Find out more about NPS RADAR.
| Title | Why read this |
|---|---|
| NPS RADAR August 2005 Professional publication - NPS RADAR - Complete issue | NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals. |
| Angiotensin II receptor antagonists: unrestricted PBS listing Professional publication - NPS RADAR - Review | Reviews new unrestricted PBS listing of candesartan, eprosartan, irbesartan, and telmisartan for hypertension, heart failure, and diabetic nephropathy. |
| Ciclesonide (Alvesco) inhaler for asthma Professional publication - NPS RADAR - Review | Reviews use of ciclesonide inhaler for asthma, with emphasis on titration to minimum dose. |
| Methylphenidate (Ritalin) for attention deficit hyperactivity disorder Professional publication - NPS RADAR - Review | Reviews use of methylphenidate for attention deficit hyperactivity disorder, including drug control issues and combination with non-drug interventions. |
| Elevated cardiovascular risk with NSAIDs? Professional publication - NPS RADAR - Review | Reviews evidence of elevated cardiovascular risk associated with COX-2 selective NSAIDs and provides guidelines for NSAID use and risk assessment. |
Complete list of all NPS RADAR content.
Find out more about NPS RADAR.
Date published: 2005-08-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.